The artificial lung (AL) technology is one of the membrane-based artificial organs that partly
augments lung functions, ie blood oxygenation and CO 2 removal. It is generally employed …

The recent outbreak of the COVID-19 pandemic in 2020 reasserted the necessity of artificial
lung membrane technology to treat patients with acute lung failure. In addition, the aging …

Despite the progress made in medical therapies for treating pulmonary hypertension (PH), a
subset of patients remain susceptible to developing a maladaptive right ventricular …

Introduction: Blood-recirculating medical devices, such as mechanical circulatory support
(MCS), extracorporeal membrane oxygenators (ECMO), and hemodialyzers, are commonly …

Recent studies show improved outcomes in ambulated lung failure patients. Ambulation still
remains a challenge in these patients. This necessitates development of more compact and …

Extracorporeal Carbon Dioxide Removal (ECCO2R) systems support patients with severe
respiratory failure. Concurrent ambulation and physical therapy improve patient outcomes …

Accurate and fast prediction of the hemodynamics of the artificial pump-lung is critical in the
design process. In this study, a comprehensive computational framework, including a sliding …

Extreme prematurity, defined as a gestational age of fewer than 28 weeks, is a significant
health problem worldwide. It carries a high burden of mortality and morbidity, in large part …

Background Right heart failure is the major cause of death in pulmonary hypertension. Lung
transplantation is the only long-term treatment option for patients who fail medical therapy …

Background There is increasing evidence demonstrating the value of partial extracorporeal
CO 2 removal (ECCO 2 R) for the treatment of hypercapnia in patients with acute …